Home/Filings/4/0001104659-17-029072
4//SEC Filing

Neos Therapeutics, Inc. 4

Accession 0001104659-17-029072

CIK 0001467652operating

Filed

May 1, 8:00 PM ET

Accepted

May 2, 9:09 PM ET

Size

7.0 KB

Accession

0001104659-17-029072

Insider Transaction Report

Form 4
Period: 2017-05-01
Martens Juergen
Chief Tech/Operations Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-05-01+45,00045,000 total
    Exercise: $7.00Exp: 2027-05-01Common Stock (45,000 underlying)
  • Award

    Common Stock

    2017-05-01+15,00025,000 total
Footnotes (2)
  • [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in four equal, annual installments beginning on May 1, 2018.
  • [F2]This stock option will vest in four equal, annual installments beginning on May 1, 2018.

Documents

1 file

Issuer

Neos Therapeutics, Inc.

CIK 0001467652

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001467652

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 9:09 PM ET
Size
7.0 KB